Clinical Research Solutions Pc is categorized under Medical Research in Knoxville, TN and active since 2004.
Clinical Research Solutions Pc was established in 2004, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact D Mathews Sellers at the company’s single location by writing to 200 East Blount Avenue # 201, Knoxville, Tennessee TN 37920 or by phoning (865) 549-4553. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Clinical Research Solutions Pc |
| Contact Person: | D Mathews Sellers |
| Address: | 200 East Blount Avenue # 201, Knoxville, Tennessee 37920 |
| Phone Number: | (865) 549-4553 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
Clinical Research Solutions Pc was started in 2004 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact D Mathews Sellers for inquiries that concern Clinical Research Solutions Pc by calling the company number (865) 549-4553, as your correspondence is most welcome. Additionally, the physical location of the single location of Clinical Research Solutions Pc can be found at the coordinates 35.955212,-83.915144 as well as the street address 200 East Blount Avenue # 201 in Knoxville, Tennessee 37920.
For its online presence, you may visit Clinical Research Solutions Pc’s website at and engage with its social media outlets through on Twitter and on Facebook.